Who Paid My Doc
Genosyl
Drug Respiratory Therapy
NDC 72385-001-01
General payments
$75,362
Research payments
$25,500
Through program year 2024, $75,362 in general payments and $25,500 in research payments were reported against Genosyl (Respiratory Therapy).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $4,408 | 9 |
| 2022 | General | $33,850 | 25 |
| 2022 | Research | $25,500 | 17 |
| 2021 | General | $17,074 | 182 |
| 2020 | General | $20,030 | 35 |
Breakdown
The top 5 of 7 recipients; each share is of general payments naming this product in 2024.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
251 general · 17 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.